Skip to content

Author

R. Dess

We have 3 of 274 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Absolute Benefit of Androgen Deprivation Therapy With Radiotherapy for Localized Prostate Cancer

Objectives: To estimate the absolute benefit of adding and prolonging androgen deprivation therapy (ADT) to radiation therapy (RT) for men with localized prostate cancer by integrating cancer-specific risk, other-cause mortality (OCM) risk, and relative treatment efficacy. Subjects and Methods: Individualized risks wer...

Jessica Aldous, W. Jackson, Elizabeth Chase et al. · 0 citations
Open access Oct 2026

Population‐level diagnostic and radiation treatment trends of low‐risk prostate cancer

Overtreatment of low‐risk prostate cancer (PC) undermines screening efforts. Active surveillance is preferred for low‐risk PC, but declining treatment may reflect diagnostic or treatment‐selection changes. We assessed diagnostic risk‐group trends among localized PC and low‐risk trends among radiation‐treated patients s...

S. Monda, Varshini S. Odayar, Maggie Yin et al. · 0 citations
Review Oct 2026

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO Clinical Practice Guideline.

HMF is recommended over conventional fractionation for patients receiving EBRT across all risk groups, supported by high-quality randomized data demonstrating equivalent oncologic outcomes, toxicity, and quality of life, with shorter treatment duration that may reduce overall treatment burden.

Scott C. Morgan, A. Halthore, Angela Y. Jia et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.